 |
5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Voisin Consulting S.A.R.L. |
| |
5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Voisin Consulting S.A.R.L. |